Search results for: etanercept

ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront

Mary Beth Nierengarten | January 1, 2013

Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights

What Rheumatologists Should Look for in Diagnosing SAPHO Syndrome

Richard Brasington, MD | November 1, 2012

SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is an obscure condition that can vex patients and clinicians

EULAR: Identify Arthritis Early, Treat it Effectively

Thomas R. Collins | October 1, 2012

Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD | September 5, 2012

Relapses are common, but difficult to predict and prevent.

EULAR 2012: Rewards in Risk Factor Research

Thomas R. Collins | September 5, 2012

Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.

EULAR 2012: Remission the New Normal for Rheumatoid Arthritis

Thomas R. Collins | August 8, 2012

Advances in the rheumatology clinic are promising, two experts say.

Drug Updates: EULAR 2012

Michele B. Kaufman, PharmD, BCGP | August 8, 2012

Tracking the results of drug safety and efficacy

California Rheumatologists Explore Managed Care, Treatment Options

Larry Beresford | July 9, 2012

Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.

Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

Gretchen Henkel | May 8, 2012

Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

Maintenance of Certification Is Not Just for the Young

James R. O’Dell, MD | March 8, 2012

I certainly am relieved to know that I will never need to recertify with the American Board of Internal Medicine Maintenance of Certification, but this feeling is shadowed by a deep sense of shame. I decided to step up and take advantage of all the wonderful recertification programs the ACR has to offer.